NewEdge Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Sell
22,953
-12,606
-35% -$1.21M 0.02% 425
2025
Q4
$3.42M Buy
35,559
+13,102
+58% +$1.27M 0.04% 322
2025
Q3
$2.03M Sell
22,457
-7,092
-24% -$652K 0.03% 394
2025
Q2
$2.7M Buy
29,549
+167
+0.6% +$14.2K 0.04% 320
2025
Q1
$2.64M Buy
29,382
+163
+0.6% +$14.6K 0.05% 294
2024
Q4
$2.33M Sell
29,219
-987
-3% -$85.4K 0.04% 317
2024
Q3
$2.72M Buy
30,206
+24,579
+437% +$2.07M 0.05% 304
2024
Q2
$443K Sell
5,627
-810
-13% -$66.4K 0.01% 575
2024
Q1
$521K Buy
+6,437
New +$549K 0.01% 556
2023
Q4
Sell
-7,428
Closed -$582K 755
2023
Q3
$582K Sell
7,428
-1,966
-21% -$165K 0.02% 444
2023
Q2
$828K Sell
9,394
-1,893
-17% -$163K 0.03% 379
2023
Q1
$910K Sell
11,287
-2,666
-19% -$217K 0.03% 323
2022
Q4
$1.08M Sell
13,953
-1,836
-12% -$149K 0.05% 282
2022
Q3
$1.27M Sell
15,789
-7,629
-33% -$686K 0.06% 246
2022
Q2
$2.1M Buy
23,418
+13,521
+137% +$1.37M 0.1% 184
2022
Q1
$1.1M Sell
9,897
-74,562
-88% -$7.88M 0.05% 217
2021
Q4
$8.74M Buy
84,459
+5,394
+7% +$625K 0.37% 70
2021
Q3
$9.91M Buy
79,065
+1,250
+2% +$162K 0.59% 41
2021
Q2
$9.66M Buy
77,815
+2,510
+3% +$315K 0.74% 37
2021
Q1
$8.9M Buy
75,305
+36,588
+95% +$4.29M 0.88% 23
2020
Q4
$4.54M Buy
+38,717
New +$4.26M 1.4% 20

Other funds holding MDT

NewEdge Wealth's MDT Position: Q1 2026 in Review

NewEdge Wealth reduced its Medtronic (MDT) stake by 35% in Q1 2026, selling an estimated $1.21M and leaving 22,953 shares worth $1.99M. The position accounts for 0.02% of the portfolio, ranked #425.

NewEdge Wealth first reported a position in MDT in Q4 2020 and has held it in 21 quarters since. The position peaked at $9.91M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • NewEdge Wealth held 22,953 shares of Medtronic worth $1.99M as of Q1 2026.
  • NewEdge Wealth sold 12,606 Medtronic shares in Q1 2026, an estimated $1.21M.
  • Medtronic made up 0.02% of NewEdge Wealth's portfolio in Q1 2026, its #425 holding.
  • NewEdge Wealth first reported a position in Medtronic in Q4 2020 and has held it in 21 quarters since.
  • NewEdge Wealth's Medtronic position peaked at $9.91M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.